Physician profile
Traci White
NPI 1316483084
$5,835.07
in general payments reported to CMS, 2019-2025
37 companies · $797 in 2025
The $797 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,342 · 2022: $1,324 · 2023: $1,266 · 2024: $1,106 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,168.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,564.20 | 2021-2025 | |
| Lilly USA, LLC | $622.63 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $594.32 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $496.72 | 2021-2025 | Freestyle Libre, Freestyle Libre 2 |
| Xeris Pharmaceuticals, INC. | $323.26 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Astrazeneca Pharmaceuticals LP | $280.41 | 2021-2025 | Breztri, Farxiga |
| Renalytix Ai, INC. | $271.17 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Novartis Pharmaceuticals Corporation | $146.55 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.27 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.80 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $119.56 | 2023 | Spravato |
| Currax Pharmaceuticals LLC | $102.29 | 2021-2023 | Onzetra Xsail, Contrave |
| Biohaven Pharmaceuticals, INC. | $95.01 | 2021 | |
| Sanofi-Aventis U.S. LLC | $92.77 | 2021-2024 | |
| Corcept Therapeutics | $91.37 | 2023-2025 | Korlym |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.